Perbedaan Brigit Biofarmaka Teknologi Tbk. dan Pudjiadi & Sons Tbk.: Brigit Biofarmaka Teknologi Tbk. diperdagangkan di Rp242 (kapitalisasi pasar 164,65 M, volume 24 jam 187,4 rb), sedangkan Pudjiadi & Sons Tbk. diperdagangkan di Rp486 (kapitalisasi pasar 382,95 M, volume 24 jam 13,5 rb). Perbedaan utamanya: Pudjiadi & Sons Tbk. jauh lebih besar — sekitar 2,3× kapitalisasi pasar Brigit Biofarmaka Teknologi Tbk., dan Brigit Biofarmaka Teknologi Tbk. lebih aktif diperdagangkan (187,4 rb vs 13,5 rb). Mana yang lebih baik tergantung tujuan investasimu.
| OBAT | PNSE | |
|---|---|---|
Kapitalisasi Pasar | 164,65 M | 382,95 M |
Volume | 187,4 rb | 13,5 rb |
Lot | 1,87 rb | 135 |
Perputaran | 44,35 jt | 6,58 jt |
Harga Rata-rata | 236,67 | 487,09 |
Nilai Transaksi | 44,35 jt | 6,58 jt |
Harga Ekuilibrium Indikatif | 242 | — |
Volume Ekuilibrium Indikatif | 500 | — |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Selengkapnya di halaman OBAT →PT Pudjiadi and Sons Tbk was established based on Notarial Deed No. 34 dated December 17, 1970 of Ridwan Suselo, s.h., notaris in Jakarta. Hotel business with all the facilities and infrastructures, such as , accommodation, office, shopping mall, apartment, recreation place and entertainment in the location of hotel. The Company is the owner of Jayakarta Hotel, a four star hotel.
Selengkapnya di halaman PNSE →